453 related articles for article (PubMed ID: 33626342)
1. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis.
Song X; Liu J; Kuang F; Chen X; Zeh HJ; Kang R; Kroemer G; Xie Y; Tang D
Cell Rep; 2021 Feb; 34(8):108767. PubMed ID: 33626342
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.
Schafer C; Young ZT; Makarewich CA; Elnwasany A; Kinter C; Kinter M; Szweda LI
J Biol Chem; 2018 May; 293(18):6915-6924. PubMed ID: 29540486
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
Tambe Y; Terado T; Kim CJ; Mukaisho KI; Yoshida S; Sugihara H; Tanaka H; Chida J; Kido H; Yamaji K; Yamamoto T; Nakano H; Omura S; Inoue H
Mol Carcinog; 2019 Oct; 58(10):1726-1737. PubMed ID: 31106493
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20.
Jiang D; Mo Q; Sun X; Wang X; Dong M; Zhang G; Chen F; Zhao Q
Cancer Sci; 2021 Sep; 112(9):3585-3597. PubMed ID: 34252986
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
[TBL] [Abstract][Full Text] [Related]
6. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathway.
Shi W; Wang J; Chen J; Jin X; Wang Y; Yang L
J Cancer Res Clin Oncol; 2024 Apr; 150(4):218. PubMed ID: 38678126
[TBL] [Abstract][Full Text] [Related]
7. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
[TBL] [Abstract][Full Text] [Related]
8. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.
Deng W; Fan W; Tang T; Wan H; Zhao S; Tan Y; Oware KA; Tan J; Li J; Qu S
Oxid Med Cell Longev; 2022; 2022():3589525. PubMed ID: 35251469
[TBL] [Abstract][Full Text] [Related]
10. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N
Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929
[TBL] [Abstract][Full Text] [Related]
11. Real-time hyperpolarized
Sharma G; Wu CY; Wynn RM; Gui W; Malloy CR; Sherry AD; Chuang DT; Khemtong C
Sci Rep; 2019 Nov; 9(1):16480. PubMed ID: 31712597
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-like factor 15 regulates fuel switching between glucose and fatty acids in brown adipocytes.
Nabatame Y; Hosooka T; Aoki C; Hosokawa Y; Imamori M; Tamori Y; Okamatsu-Ogura Y; Yoneshiro T; Kajimura S; Saito M; Ogawa W
J Diabetes Investig; 2021 Jul; 12(7):1144-1151. PubMed ID: 33480176
[TBL] [Abstract][Full Text] [Related]
14. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype.
Min BK; Park S; Kang HJ; Kim DW; Ham HJ; Ha CM; Choi BJ; Lee JY; Oh CJ; Yoo EK; Kim HE; Kim BG; Jeon JH; Hyeon DY; Hwang D; Kim YH; Lee CH; Lee T; Kim JW; Choi YK; Park KG; Chawla A; Lee J; Harris RA; Lee IK
Front Immunol; 2019; 10():944. PubMed ID: 31134063
[TBL] [Abstract][Full Text] [Related]
16. Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Kageyama S; Kawauchi A; Inoue H
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982789
[TBL] [Abstract][Full Text] [Related]
17. Metabolic checkpoint of ferroptosis resistance.
Liu J; Kang R; Tang D
Mol Cell Oncol; 2021; 8(3):1901558. PubMed ID: 34027040
[TBL] [Abstract][Full Text] [Related]
18. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
Mori J; Alrob OA; Wagg CS; Harris RA; Lopaschuk GD; Oudit GY
Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1103-13. PubMed ID: 23396452
[TBL] [Abstract][Full Text] [Related]
19. Hyperpolarized NMR study of the impact of pyruvate dehydrogenase kinase inhibition on the pyruvate dehydrogenase and TCA flux in type 2 diabetic rat muscle.
Park JM; Josan S; Hurd RE; Graham J; Havel PJ; Bendahan D; Mayer D; Chung Y; Spielman DM; Jue T
Pflugers Arch; 2021 Nov; 473(11):1761-1773. PubMed ID: 34415396
[TBL] [Abstract][Full Text] [Related]
20. MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer.
Miao Y; Li Q; Sun G; Wang L; Zhang D; Xu H; Xu Z
Cancer Med; 2020 Oct; 9(19):7231-7243. PubMed ID: 32780563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
